Abstract
Advanced kernel-based machine learning methods enable the identification of innovative bioactive compounds with minimal experimental effort. Comparative virtual screening revealed that nonlinear models of the underlying structure-activity relationship are necessary for successful compound picking. In a proof-of-concept study a novel truxillic acid derivative was found to selectively activate transcription factor PPARγ. (Chemical Equation Presented)
Original language | English |
---|---|
Pages (from-to) | 191-194 |
Number of pages | 4 |
Journal | ChemMedChem |
Volume | 5 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2010 Feb 1 |
Keywords
- Drug design
- Machine learning
- NMR
- Natural products
- Virtual screening
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Pharmacology
- Drug Discovery
- Pharmacology, Toxicology and Pharmaceutics(all)
- Organic Chemistry